-
2022 has come to an end and, without a doubt, it has been a year full of goals, challenges, changes, restructuring and learning, but also many achievements at the institutional and country level. A year marked by adversity and in which we have managed to recover each time with intelligence, innovation and commitment.
We want to thank you in advance for your trust and support. We are very proud to see the great progress of our institution, backed by a work team that strives daily to keep the legacy and history of the CNIC alive.
-
"Mothers are love, not reason; they are exquisite sensitivity and inconsolable pain ... Every mother should be called wonder." Jose Marti.
CONGRATULATIONS MOM
-
Today our Point of Sale of Products of Natural Origin reopened (April 15, 2021) located at Av. 25 corner 21A, Reparto Cubanacán. As a result of the economic and financial ordering process, the retail prices of natural products that are subsidized by the state budget were maintained. Sales Hours: 8:30 am -4:30 pm from Monday to Friday. Visit us! #For a healthy life.
-
Considered a milestone for a developing country and subjected to a strict economic blockade for almost 60 years, ten products of Cuban science hold, to date, the WIPO Gold Medal. The CNIC is honored to have two of our innovative products on this short list of results that have achieved the WIPO Gold Medal: PPG, a drug made from sugarcane wax, and DIRAMIC, a team for the rapid microbiological diagnosis.
-
The study and application of modern methods for evaluating atmospheric corrosion in Cuba is an important technological contribution to the country, constituting one of the lines that make up the package of institutional services developed by the CNIC. This is how the article published by Granma stands out today.
-
The First Secretary of the PCC in Havana Luis Torres Iribar, visited the CNIC accompanied by Dr. Eduardo Martinez, President of BioCubaFarma. On his tour, he expressed his satisfaction with the remarkable improvement of the center even in difficult times of COVID.
2022 has come to an end and, without a doubt, it has been a year full of goals, challenges, changes, restructuring and learning, but also many achievements at the institutional and country level. A year marked by adversity and in which we have managed to recover each time with intelligence, innovation and commitment. We want to thank you in advance for your trust and support. We are very proud to see the great progress of our institution, backed by a work team that strives daily to keep the legacy and history of the CNIC alive.
"Mothers are love, not reason; they are exquisite sensitivity and inconsolable pain ... Every mother should be called wonder." Jose Marti. CONGRATULATIONS MOM
Today our Point of Sale of Products of Natural Origin reopened (April 15, 2021) located at Av. 25 corner 21A, Reparto Cubanacán. As a result of the economic and financial ordering process, the retail prices of natural products that are subsidized by the state budget were maintained. Sales Hours: 8:30 am -4:30 pm from Monday to Friday. Visit us! #For a healthy life.
Considered a milestone for a developing country and subjected to a strict economic blockade for almost 60 years, ten products of Cuban science hold, to date, the WIPO Gold Medal. The CNIC is honored to have two of our innovative products on this short list of results that have achieved the WIPO Gold Medal: PPG, a drug made from sugarcane wax, and DIRAMIC, a team for the rapid microbiological diagnosis.
The study and application of modern methods for evaluating atmospheric corrosion in Cuba is an important technological contribution to the country, constituting one of the lines that make up the package of institutional services developed by the CNIC. This is how the article published by Granma stands out today.
The First Secretary of the PCC in Havana Luis Torres Iribar, visited the CNIC accompanied by Dr. Eduardo Martinez, President of BioCubaFarma. On his tour, he expressed his satisfaction with the remarkable improvement of the center even in difficult times of COVID.